Bristol-Myers Squibb - 28 Year Dividend History | BMY

Historical dividend payout and yield for Bristol-Myers Squibb (BMY) since 1990. The current TTM dividend payout for Bristol-Myers Squibb (BMY) as of August 15, 2018 is $1.60. The current dividend yield for Bristol-Myers Squibb as of August 15, 2018 is 2.69%.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $97.124B $20.776B
Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Their employees around the world work together for patients - it drives everything they do. They are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through their R&D organization, they have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate their work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $349.368B 16.69
Pfizer (PFE) United States $242.936B 14.22
Novartis AG (NVS) Switzerland $191.051B 16.39
Merck (MRK) United States $179.890B 15.89
AbbVie (ABBV) United States $146.551B 14.32
Novo Nordisk (NVO) Denmark $115.579B 18.48
Eli Lilly (LLY) United States $110.019B 20.37
Sanofi (SNY) France $104.111B 13.18
AstraZeneca (AZN) United Kingdom $98.834B 10.87
GlaxoSmithKline (GSK) United Kingdom $98.627B 13.17